https://www.selleckchem.com/products/r16.html
2% vs 21.4%; P less then .001; scaliness 91.3% vs 61.2%; P less then .001; and thickness 83.3% vs 35.0%; P less then .001, respectively). Rapid onset of efficacy was observed as early as week 1. Significantly more patients also achieved TSS-50 at week 4 with Cal/BD foam vs vehicle foam for their target lesions regardless of treatment area, including the elbows and knees (P less then .05 for all). CONCLUSIONS Significant improvements in target lesion severity were achieved with up to 4 weeks of treatment with once-daily Cal/BD foam for adult
Like
Comment
Share
